Responsive risk assessment tool for drug criticality and vulnerability…
| Location: | Federal |
|---|---|
| Posted: | Feb 24, 2026 |
| Due: | Mar 9, 2026 |
| Agency: | Government of Canada |
| Type of Government: | State & Local |
| Category: |
|
| Solicitation No: | 1000269703 |
| Publication URL: | To access bid details, please log in. |
Description
Health Canada has a requirement for access to information products to support the determination of shortage risk for drugs and the maintenance CVDL. We require that these information products provide us data and risk assessments showing the likelihood that a shortage of a drug would cause harm (criticality) and the likelihood of a drug going into shortage (vulnerability). The data must be on a web platform that can be accessed by Health Canada employees.
The estimated contract period will be 12 month(s), with a proposed start date of 2026/03/23.
-
Canada-Chile Free Trade Agreement (CCFTA)
-
Canada-Peru Free Trade Agreement (CPFTA)
-
Canada-Colombia Free Trade Agreement
-
Canada-Panama Free Trade Agreement
-
Canada-Honduras Free Trade Agreement
-
Canada-Korea Free Trade Agreement (CKFTA)
-
Canadian Free Trade Agreement (CFTA)
A contracting officer can use limited tendering for specific reasons outlined in the applicable trade agreements. The reason for this contract is described below:
-
Exclusive Rights
Are you interested in partnering with other businesses for this opportunity? Add your company to the list of businesses who are interested in partnering .
This list does not replace or affect the tendering procedures for this procurement process. Businesses are still required to respond to bid solicitations, and to compete based on the set criteria. For more information please read the Terms of use .
With GovernmentContracts, you can:
- Find more opportunities and win more business
- Receive daily alerts for all new bid opportunities
- Get contract opportunities matched to your business